Table 2

Sociodemographic data, spirometry, level of control of asthma symptoms and anxiety/depression of study patients

VariablesBaseline visit
(n=3183)
Telephone survey at 3 months
(n=3057)
Final visit at 6 months
(n=2902)
p Value (final vs baseline visits)
Sociodemographic data
 Women, n (%)1948 (61.2)
 Age, years, mean (SD)46.8 (16.7)
 Smoking status
  Current smoker391 (12.3)
  Ex-smoker757 (23.8)
  Never smoker2034 (63.9)
  Civil status
  Married or lived with a partner2082 (65.4)
  Single820 (25.8)
  Separated or widowed281 (8.8)
 Years since asthma diagnosis, mean (SD)7.6 (9.6)
 Severity of asthma, n (%)
  Moderate2577 (81.0)
  Severe605 (19.0)
Exacerbations in the last 6 months, mean (SD)2.3 (1.8)
Asthma control and spirometry
 ACT score, mean (SD)15.8 (4.7)19.3 (4.2)19.4 (4.4)<0.001
 Patients with controlled asthma (ACT ≥20), n (%)785 (24.7)1700 (55.6)1667 (57.5)<0.001
 FEV1, %, mean (SD)81.6 (20.9)86.0 (20.8)<0.001
HADS
 Anxiety subscale score, mean (SD)7.1 (4.3)5.9 (4.2)<0.001
 Patients with anxiety (score ≥11), n (%)769 (24.2)445 (15.3)<0.001
 Depression subscale score, mean (SD)5.2 (4.1)4–4 (4.0)<0.001
 Patients with depression (score ≥11), n (%)373 (11.7)234 (8.1)<0.001
  • ACT, asthma control test; FEV1, forced expiratory volume in first second; HADS, Hospital Anxiety Depression Scale.